Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1482.1034.2 (+2.36 %)
PREV CLOSE () 1447.90
OPEN PRICE () 1451.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9565
TODAY'S LOW / HIGH ()1434.05 1509.05
52 WK LOW / HIGH ()1200 1594.55
NSE1479.7032.6 (+2.25 %)
PREV CLOSE() 1447.10
OPEN PRICE () 1448.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1479.70 (198)
VOLUME 100371
TODAY'S LOW / HIGH() 1434.20 1509.80
52 WK LOW / HIGH ()1168.2 1595
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1949

Management Info :

Premchand Godha - Chairman Pranay Godha - Managing Director

Registered Office :

Address : 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone : 022- 66474444 / 62106050

Email : ipca@ipca.com

Website : www.ipca.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
22Jan Ipca Laboratories informs about board
Ipca Laboratories has informed that the meeting of the Board of Director..
13Jan Ipca Laboratories informs about updates
Ipca Laboratories has informed that it enclosed details regarding sale o..
22Dec Ipca Laboratories informs about closur
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015,..
05Dec USFDA conducts inspection at Ipca Labo
The United States Food and Drug Administration (USFDA) has conducted the..
12Nov Ipca Laboratories informs about confer
Further to intimation dated 6th November, 2025 and in accordance with Re..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit3047.46507.6
Gross Profit 4083.1 9997.7
Operating Profit 4866.315963.2
Net Sales 19303.266779.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
 1799.40 (6.56%)
M.Cap ( in Cr)
29646.27
NGL Fine-Chem (BSE)
 1785.00 (4.58%)
M.Cap ( in Cr)
1102.78
Acutaas Chemicals (BSE)
 1936.00 (3.84%)
M.Cap ( in Cr)
15850.25
Windlas Biotech (BSE)
 823.95 (4.76%)
M.Cap ( in Cr)
1736.66
Venus Remedies (BSE)
 784.65 (3.24%)
M.Cap ( in Cr)
1048.84
Shareholding Pattern
PROMOTERS 44.72%
MUTUAL FUNDS/UTI 30.52%
NON-INSTITUTION 7.33%
FI/BANKS/INSURANCE 6.15%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX82566.37221.69 (0.27%)
NIFTY25418.9076.15 (0.30%)
Dow Jones 49015.6012.19 (0.02%)
Nasdaq 23857.4540.35 (0.17%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI